These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21296365)

  • 1. [Visfatin in obese patients, relation with cardiovascular risk factors, a cross sectional study].
    de Luis DA; Ballesteros M; Ruiz E; Muñoz C; Penacho A; Iglesias P; Guzmán AL; Abreu C; Maldonado A; Delgado M; Martín LS; Puigdevall V; Romero E; Sagrado MG; Izaola O; Conde R;
    Med Clin (Barc); 2011 Jul; 137(5):199-203. PubMed ID: 21296365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
    de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
    Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
    Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
    Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose.
    de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O
    Nutrition; 2013; 29(11-12):1300-3. PubMed ID: 19131213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum visfatin levels and metabolic syndrome criteria in obese female subjects.
    de Luis DA; Aller R; Gonzalez Sagrado M; Conde R; Izaola O; de la Fuente B
    Diabetes Metab Res Rev; 2013 Oct; 29(7):576-81. PubMed ID: 23704051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum visfatin levels in women with polycystic ovary syndrome.
    Güdücü N; İşçi H; Görmüş U; Yiğiter AB; Dünder I
    Gynecol Endocrinol; 2012 Aug; 28(8):619-23. PubMed ID: 22313145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of visfatin levels with insulin resistance and left ventricular hypertrophy in peritoneal dialysis patients.
    Karakan S; Sezer S; Özdemir Acar FN; Haberal M
    Ren Fail; 2012; 34(6):732-7. PubMed ID: 22503095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
    Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma visfatin concentrations in childhood obesity: relationships with insulin resistance and anthropometric indices.
    Davutoglu M; Ozkaya M; Guler E; Garipardic M; Gursoy H; Karabiber H; Kilinc M
    Swiss Med Wkly; 2009 Jan; 139(1-2):22-7. PubMed ID: 19142752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women.
    De Luis DA; Conde R; Gonzalez Sagrado M; Aller R; Izaola O; Perez Castrillon JL; Romero E; Castro MJ
    Eur Rev Med Pharmacol Sci; 2010 Sep; 14(9):759-63. PubMed ID: 21061834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients.
    Mirzaei K; Hossein-Nezhad A; Javad Hosseinzadeh-Attar M; Jafari N; Najmafshar A; Mohammadzadeh N; Larijani B
    Minerva Endocrinol; 2009 Dec; 34(4):273-9. PubMed ID: 20046156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body fat distribution has no effect on serum visfatin levels in healthy female subjects.
    Ersoy C; Sadikoglu G; Orhan H; Guclu M; Sarandol E; Akgun MD; Ozcakir A; Imamoglu S
    Cytokine; 2010 Mar; 49(3):275-8. PubMed ID: 20045351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum visfatin levels, adiposity and glucose metabolism in obese adolescents.
    Taşkesen D; Kirel B; Us T
    J Clin Res Pediatr Endocrinol; 2012 Jun; 4(2):76-81. PubMed ID: 22672864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
    Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated visfatin levels in obese children are related to proinflammatory factors.
    Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL
    J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum visfatin levels in a group of Egyptian obese individuals.
    Reda R; Shehab A; Soliman D; Gabr A; Abbass A
    Egypt J Immunol; 2011; 18(1):25-32. PubMed ID: 23082477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selected adipokines and metabolic profiles in normal-weight women with abdominal obesity.
    Miazgowski T; Major-Gołuch A; Safranow K
    Pol Arch Med Wewn; 2012; 122(9):406-12. PubMed ID: 22814438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.
    Caixàs A; Tirado R; Vendrell J; Gallart L; Megía A; Simón I; Llauradó G; González-Clemente JM; Giménez-Palop O
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):733-8. PubMed ID: 19222486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.
    Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P
    Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparison of serum vaspin and visfatin concentrations in obese and normal weight women.
    Saboori S; Hosseinzadeh-Attar MJ; Yousefi Rad E; Hosseini M; Mirzaei K; Ahmadivand Z
    Diabetes Metab Syndr; 2015; 9(4):320-3. PubMed ID: 25470626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.